Scholars Central

Conference abstractPublished 27 Jul 2015

Mesenchymal stem cells offer multi-mechanistic approaches for mitigation of degenerated dopaminergic neurons

Authors: Hanaa H Ahmed, Fateheya Metwally, Wagdy K B Khalil, Hadeer A Aglan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Parkinsonâ??s disease (PD) has been considered a paradigm of degenerative diseases of the nervous system characterized by motor impairment due to malfunction and loss of dopaminergic neurons. Currently there is no therapy clinically available that delays the neurodegenerative process; therefore modification of the disease course is an unmet clinical need. Mesenchymal stem cells (MSCs) have been considered as a promising therapeutic strategy for acute injury and degenerative diseases of the central nervous system. Objective: The current work aimed to elucidate the possible role of single intravenous dose of bone marrow derived MSCs (BMMSCs) in restraining dopaminergic neurons in experimental model after 2 months. Materials & Methods: Thirty two ovariectomized animals were classified into 4 groups; Group (1) was control, Groups from (2) to (4) were subcutaneously administered with rotenone for 14 days after one month of ovariectomy for induction of PD. Group (2) was left untreated; Groups (3) and (4) were treated with sinemet and BM-MSCs respectively. Y-chromosome gene (sry) was assessed by PCR in brain tissue of the female rats. Serum TGF-β1 and MCP-1 levels were assayed by ELISA technique. Brain dopamine level was assayed fluorometrically while, brain TH and nestin genes expression were detected by sqRT-PCR. Results: The data of the current work revealed that BM-MSCs were able to home at the injured brains and produced significant decrease in serum TGF-β1 and MCP-1 levels associated with significant increase in brain dopamine content, brain TH and nestin genes expression levels. Conclusion: The observed improvements in the studied biomarkers after 2 months from intravenous transplantation of BM-MSCs sheds light on the promising role of BM-MSCs in ameliorating neurodeterioration of dopaminergic neurons through their antiinflammatory and neurogenic effects.

Subjects

Engineering

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Tissue Science and Engineering.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Tissue Science and Engineering
  • SubjectEngineering
  • BylineArticles whose byline prints “Hanaa H Ahmed”
  • BylineArticles whose byline prints “Fateheya Metwally”
  • BylineArticles whose byline prints “Wagdy K B Khalil”
  • BylineArticles whose byline prints “Hadeer A Aglan”